封面
市場調查報告書
商品編碼
1678695

全球原代細胞培養市場:市場規模、佔有率、趨勢分析(按產品、細胞類型、應用、最終用途和地區)、細分市場預測(2025-2030 年)

Primary Cell Culture Market Size, Share & Trends Analysis Report By Product (Primary Cells, Media), By Cell Type (Human Cells, Animal Cells) By Application (Cell & Gene Therapy Development), By End-use, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

原代細胞培養市場的成長與趨勢:

根據 Grand View Research, Inc. 的一份新報告,全球原代細胞培養市場預計到 2030 年將達到 86.7 億美元。

預計 2025 年至 2030 年期間,市場複合年成長率為 10.55%。個人化和精準醫療的需求日益成長,推動了對更準確、更相關的體外模型的需求。原代細胞培養是研究疾病機制、藥物發現和治療方法開發的重要工具,因為與傳統細胞株相比,它們更緊密地重現人類生物學和生理學。越來越多的研究人員和製藥公司意識到原代細胞培養的重要性,它可以提高治療候選藥物的成功率,減少昂貴的後期失敗,並最終為患者提供更有效、更有針對性的治療方法。

此外,在旨在替換或修復受損組織和器官的再生醫學領域,原代細胞培養在功能組織的發育和工程中發揮關鍵作用。原代細胞用於產生與天然組織的結構和功能非常相似的組織結構、類器官和生物工程植入。這些進展將對組織移植、創傷治療和退化性疾病治療等再生醫學療法產生重大影響。例如,2023 年 4 月,西奈山推出了新的再生醫學研究所,以促進新發現並探索危及生命的疾病的新治療方法。人們對再生醫學及其徹底改變醫療保健的潛力的興趣日益濃厚,導致對原代細胞培養的投資和研究增加,從而推動了市場的成長。

COVID-19疫情對原代細胞培養產業產生了重大影響。這場大流行擾亂了醫療保健和研究等各個行業,但也凸顯了原代細胞培養在了解病毒和開發治療方法的關鍵作用。原代細胞可用於研究 SARS-CoV-2 感染機制、測試抗病毒療法和評估疫苗功效。隨著世界各地的研究人員將重點放在與 COVID-19 相關的研究,疫情加速了對原代細胞培養產品和服務的需求。

此外,主要市場參與企業的多項發展和日益成長的產學合作正在推動全球市場的發展。例如,2023 年 1 月,Bio-Trac 和 ATCC 合作舉辦了一個培訓研討會,概述了原代細胞培養原理、類器官和球體以及其他相關的細胞培養技術。

原代細胞培養市場:分析概述

  • 根據產品,試劑和補充劑部分在 2024 年佔據 37.7% 的佔有率。這是由於針對特定細胞類型和研究應用的高品質試劑和補充劑廣泛可用。
  • 根據分離方法,酵素水解部分在 2024 年佔據市場主導地位,佔有率為 32.15%。此方法的優點包括對培養物的損害最小、週轉時間相對較短、樣品產量大。
  • 根據細胞類型,動物細胞部分預計在預測期內將出現高速成長。這一領域的高成長歸因於這種細胞類型的多功能性、廣泛的可用性以及已建立的研究協議。
  • 由於高度發展的醫療保健基礎設施和有利的政府政策,北美在全球市場中佔據了強大的區域地位,到 2024 年其佔有率將達到 41.58%。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章 原代細胞培養市場:促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第 4 章 原代細胞培養市場:按產品分類的業務分析

  • 細分儀表板:依產品
  • 全球原代細胞培養市場:依產品變異分析
  • 全球原代細胞培養市場規模及產品趨勢分析(2018-2030)
  • 原代細胞
  • 培養基
  • 試劑和補充劑

第 5 章 原代細胞培養市場:按應用的業務分析

  • 細分儀表板:依用途
  • 全球原代細胞培養市場:依應用進行變異分析
  • 全球原代細胞培養市場規模及應用趨勢分析(2018-2030)
  • 疫苗生產
  • 細胞和基因治療藥物的開發
  • 模型系統
  • 病毒學
  • 產前檢查
  • 其他用途

第 6 章 原代細胞培養市場:依細胞類型進行的商業分析

  • 細分儀表板:按細胞類型
  • 全球原代細胞培養市場:依細胞類型進行變異分析
  • 全球原代細胞培養市場規模及趨勢分析(依細胞類型) (2018-2030)
  • 人類細胞
  • 動物細胞

第 7 章 原代細胞培養市場:依最終用途的商業分析

  • 細分儀表板:依最終用途
  • 全球原代細胞培養市場:依最終用途進行變異分析
  • 全球原代細胞培養市場規模及趨勢分析(依最終用途) (2018-2030)
  • 製藥和生物技術公司
  • 合約行銷/合約風險評估
  • 學術研究所

第 8 章 原代細胞培養市場:區域估計和趨勢分析(按產品、應用和最終用途)

  • 區域控制面板
  • 市場規模預測及趨勢分析(2018-2030年)
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 參與企業
  • 戰略地圖
  • 企業市場分析(2024年)
  • 參與企業概況
    • Thermo Fisher Scientific Inc.
    • STEMCELL Technologies
    • Merck KGaA
    • Lonza
    • Cell Biologics, Inc.
    • PromoCell GMBH
    • ZenBio
    • AllCells
    • American Type Culture Collection
    • Axol Biosciences Ltd.
Product Code: GVR-2-68038-590-8

Primary Cell Culture Market Growth & Trends:

The global primary cell culture market size is anticipated to reach USD 8.67 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.55% from 2025 to 2030. The increasing demand for personalized and precision therapies has fueled the need for more accurate and relevant in vitro models. Primary cell culture provides a closer representation of human biology and physiology compared to traditional cell lines, making it an indispensable tool for studying disease mechanisms, drug discovery, and therapeutic development. Researchers and pharmaceutical companies are increasingly recognizing the importance of primary cell culture for improving the success rates of drug candidates, reducing costly late-stage failures, and ultimately delivering more effective and targeted treatments to patients.

Moreover, the field of regenerative medicine aims to replace or repair damaged tissues and organs, and primary cell culture plays a vital role in developing and engineering functional tissues. Primary cells are used to create tissue constructs, organoids, and bioengineered implants that closely mimic the structure and function of native tissues. These advancements have significant implications for regenerative medicine therapies, including tissue transplantation, wound healing, and the treatment of degenerative diseases. For instance, in April 2023, Mount Sinai launched a new institute for regenerative medicine to foster novel discoveries and explore new therapies for life-threatening diseases. The growing interest in regenerative medicine and the potential to revolutionize healthcare have led to increased investment and research in primary cell culture, propelling the market's growth.

The COVID-19 pandemic has significantly impacted the primary cell culture industry. While the pandemic disrupted various industries, including healthcare and research, it highlighted the crucial role of primary cell culture in understanding viruses and developing treatments. Primary cells have been instrumental in studying the mechanisms of SARS-CoV-2 infection, testing antiviral therapies, and evaluating vaccine efficacy. The pandemic has accelerated the demand for primary cell culture products and services as researchers worldwide focused on COVID-19-related studies.

Furthermore, several developments undertaken by key market participants, and increasing industry-academia collaborations are driving the global market. For instance, in January 2023, Bio-Trac and ATCC collaborated to conduct a training workshop to offer an overview of the principles of primary cell culture, organoids and spheroids, and other related cell culture techniques.

Primary Cell Culture Market Report Highlights:

  • By product, the reagent and supplements segment dominated with a share of 37.7% in 2024, due availability of a wide range of high-quality reagents and supplements tailored for specific cell types and research applications
  • By separation method, the enzymatic degradation segment dominated the market with a share of 32.15% in 2024, due to the advantages of this method such as less damage to cultures, a relatively short turnaround time, and a high output of sample representation
  • By cell type, the animal cells segment is expected to grow lucratively over the forecast period. The high growth of the segment is attributed to the versatility, wide availability, and established research protocols for this cell type
  • North America established a strong regional position in the global market with a 41.58% share in 2024 due to its highly developed healthcare infrastructure and favorable government policies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Cell Type Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising usage of primary cell culture products in in-vitro testing and drug screening
      • 3.2.1.2. Increasing in demand for stem cell therapy and regenerative medicine
      • 3.2.1.3. Rising incidence of cancer and other chronic diseases
      • 3.2.1.4. Advancement in genetic engineering protocols
      • 3.2.1.5. Rise in research funding for functional biology and research
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Ethical and regulatory concerns related with the use of primary cells
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Primary Cell Culture Market: Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Global Primary Cell Culture Market Product Movement Analysis
  • 4.3. Global Primary Cell Culture Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Primary Cells
    • 4.4.1. Global Primary Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Hematopoietic Cells
      • 4.4.2.1. Hematopoietic cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Skin Cells
      • 4.4.3.1. Skin cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Hepatocytes
      • 4.4.4.1. Hepatocytes market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. Gastrointestinal Cells
      • 4.4.5.1. Gastrointestinal cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. Lung Cells
      • 4.4.6.1. Lung cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Renal Cells
      • 4.4.7.1. Renal cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.8. Heart Cells
      • 4.4.8.1. Heart cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.9. Skeletal and Muscle Cells
      • 4.4.9.1. Skeletal and muscle cells market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.10. Other Primary Cells
      • 4.4.10.1. Other primary cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Media
    • 4.5.1. Global Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Serum-free Media
      • 4.5.2.1. Global Serum-free Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Serum-containing Media
      • 4.5.3.1. Global Serum-containing Media Market and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Other Media
      • 4.5.4.1. Global Other Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Reagents and Supplements
    • 4.6.1. Global Reagents and Supplements Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Attachment Solutions
      • 4.6.2.1. Global Attachment Solutions Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Buffers and Salts
      • 4.6.3.1. Global Buffers and Salts Market and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Sera
      • 4.6.4.1. Global Sera Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Growth Factors and Cytokines
      • 4.6.5.1. Global Growth Factors and Cytokines Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Freezing Media
      • 4.6.6.1. Global Freezing Media Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.7. Others
      • 4.6.7.1. Global Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Primary Cell Culture Market: Application Business Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Global Primary Cell Culture Market Application, Movement Analysis
  • 5.3. Global Primary Cell Culture Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Vaccine Production
    • 5.4.1. Global Vaccine Production Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cell & Gene Therapy Development
    • 5.5.1. Global Cell & Gene Therapy Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Model System
    • 5.6.1. Global Model System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Virology
    • 5.7.1. Global Virology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Prenatal Diagnosis
    • 5.8.1. Global Prenatal Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Other Applications
    • 5.9.1. Global Other Applications Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Primary Cell Culture Market: Cell Type Business Analysis

  • 6.1. Cell Type Segment Dashboard
  • 6.2. Global Primary Cell Culture Market Cell Type Movement Analysis
  • 6.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Human Cells
    • 6.4.1. Global Human Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Animal Cells
    • 6.5.1. Global Animal Cells Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Primary Cell Culture Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Primary Cell Culture Market End Use Movement Analysis
  • 7.3. Global Primary Cell Culture Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Global Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. CMOs & CROs
    • 7.5.1. Global CMOs & CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Academic Research Institutes
    • 7.6.1. Global Academic Research Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Primary Cell Culture Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Primary Cell Culture Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Participant's Overview
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. STEMCELL Technologies
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. Merck KGaA
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. Lonza
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Cell Biologics, Inc.
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. PromoCell GMBH
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. ZenBio
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. AllCells
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. American Type Culture Collection
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Axol Biosciences Ltd.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Primary Cell Culture market, by product, 2018 - 2030 (USD Million)
  • Table 3 Primary Cell Culture market, by end use, 2018 - 2030 (USD Million)
  • Table 4 Primary Cell Culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 5 Primary Cell Culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 Primary Cell Culture market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 10 North America primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 11 North America primary culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 15 U.S. primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 16 Canada primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Canada primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 19 Canada primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 20 Mexico primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Mexico primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 23 Mexico primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Europe primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 28 Europe primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 29 UK primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 31 UK primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 32 UK primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 33 Germany primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 36 Germany primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 37 France primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 38 France primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 39 France primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 40 France primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 41 Italy primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Italy primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 44 Italy primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 45 Spain primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Spain primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 48 Spain primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 49 Denmark primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Denmark primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 52 Denmark primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 53 Sweden primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Sweden primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 56 Sweden primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 57 Norway primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Norway primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 60 Norway primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 66 Japan primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Japan primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 69 Japan primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 70 China primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 71 China primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 72 China primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 73 China primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 74 India primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 75 India primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 76 India primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 77 India primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 78 Australia primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 80 Australia primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 81 Australia primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 82 Thailand primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 84 Thailand primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 85 Thailand primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Korea primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 87 South Korea primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 88 South Korea primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 89 South Korea primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Latin America primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 94 Latin America primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 95 Brazil primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 97 Brazil primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 98 Brazil primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 99 Argentina primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Argentina primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 102 Argentina primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 103 Middle East & Africa primary cell culture market, by country, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 108 South Africa primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 110 South Africa primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 111 South Africa primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 116 UAE primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 118 UAE primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 119 UAE primary cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 120 Kuwait primary cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait primary cell culture market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Kuwait primary cell culture market, by cell type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait primary cell culture market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Primary Cell Culture market segmentation
  • Fig. 7 Market snapshot, 2024
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis
  • Fig. 10 Market restraint relevance analysis
  • Fig. 11 PESTEL analysis
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Primary Cell Culture market: Product movement analysis
  • Fig. 14 Primary Cell Culture market, for primary cells, 2018 - 2030 (USD Million)
  • Fig. 15 Primary Cell Culture market, for reagents and supplements, 2018 - 2030 (USD Million)
  • Fig. 16 Primary Cell Culture market, for media, 2018 - 2030 (USD Million)
  • Fig. 17 Primary Cell Culture market: end use movement analysis
  • Fig. 18 Primary Cell Culture market, for pharmaceutical and biotechnology companies
  • Fig. 19 Primary Cell Culture market, for CMOs & CROs
  • Fig. 20 Primary Cell Culture market, for Academic Research Institutes
  • Fig. 21 Primary Cell Culture market: Cell Type movement analysis
  • Fig. 22 Primary Cell Culture market, for animal cells, 2018 - 2030 (USD Million)
  • Fig. 23 Primary Cell Culture market, for human cells, 2018 - 2030 (USD Million)
  • Fig. 24 Primary Cell Culture market: Application movement analysis
  • Fig. 25 Primary Cell Culture market, for cell & gene therapy development, 2018 - 2030 (USD Million)
  • Fig. 26 Primary Cell Culture market, for vaccine production, 2018 - 2030 (USD Million)
  • Fig. 27 Primary Cell Culture market, for model system, 2018 - 2030 (USD Million)
  • Fig. 28 Primary Cell Culture market, for virology, 2018 - 2030 (USD Million)
  • Fig. 29 Primary Cell Culture market, for prenatal diagnosis, 2018 - 2030 (USD Million)
  • Fig. 30 Primary Cell Culture market, for others applications, 2018 - 2030 (USD Million)
  • Fig. 31 Regional marketplace: Key takeaways
  • Fig. 32 Regional outlook, 2024 & 2030
  • Fig. 33 Primary Cell Culture market: Region movement analysis
  • Fig. 34 North America Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 38 Europe Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 40 UK Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 41 France Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 43 Spain Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 44 Denmark Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 48 Japan Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 49 China Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 50 India Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 60 UAE Primary Cell Culture market, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait Primary Cell Culture market, 2018 - 2030 (USD Million)